Medical Industry Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Medical Industry Today.

Press releases published on October 8, 2026

Taction Software Expands Telemedicine and EHR-Integrated Healthcare App Development Services
Lifebit Launches Impact Fund to Help Lower-Income Countries & Research Organisations Tackle Research Funding Challenges
Holistic Health Practitioner RoxAnne Eli Launches RED DRESS™ Method for Women Leaders
Sage Healthcare and Roth Capital Partners Announce European Healthcare Collaboration
CyberTwin’s Digital Twins Can Now Guide Teams Through the Real Facility, Step by Step, Powered by MultiSet AI
Hela Launches: Clinical-Grade Medical AI With Every Answer Traced to a Source
Constar Launches Single-Source Retail-Ready Packaging for Private Label Contact Lens Brands
Graphy and MegaGen Sign Initial KRW 2 Billion Supply Agreement for Dental 3D Printing Materials and Equipment
Medical Marketing Whiz Shares 9 Holiday Marketing Ideas for Med Spas to Fill the Schedule and Set Up a Strong 2027
Medical Marketing Whiz Launches Webinar Replay Showing Medical Practices How to Own the Menopause Market
She Innovates AI Introduces GEO-VIS Framework to Measure Brand Visibility in AI Search
Grace O. Abejide Becomes First Canadian Trichologist to Earn Fellowship Designation from the IAT
Five Reputable Tablet Press Manufacturers in China 2026: Advancing Pharmaceutical Manufacturing
Lakewood-Amedex Announces Positive Preclinical Bisphosphocin® Compound Data in Urinary Tract and Pulmonary Infections
Kingdom of Companion Animal Primary Cells: How Cloud-Clone Reshapes the Global Landscape of Pet Health Research
Cloud-Clone Primary Cardiac Cells: High-Fidelity In-vitro Models for Cardiovascular Research and Drug Evaluation
Behavidence in Advanced Discussions With Global Android Smartphone Manufacturers Following Strong Demand for NEURA
Addex Spin-Out Neurosterix Completes Phase 1 Clinical Studies of NTX-253 for Schizophrenia
argenx Announces Positive Topline Results from Phase 2 Study of FB102 in Celiac Disease
argenx Provides Update on Phase 3 UNITY Study of Efgartigimod SC in Sjögren's Disease

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Medical Industry Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.